北美放射性药物市场预测至 2028 年 - COVID-19 影响和区域分析（按类型（诊断核医学和治疗核医学）、应用（肿瘤学、心脏病学、神经病学等）和最终用户（医院、影像中心、学术和医院）研究中心等）
市场介绍
北美放射性药物市场以美国、加拿大和墨西哥三个主要国家为基础进行分析。美国拥有规模最大的放射性药物市场。由于先进的医疗基础设施的可用性、目标病症的发病率和患病率的上升以及该地区主要参与者推出的产品创新，预计该市场将增长。用于治疗用途的靶向放射性药物将放射性核素直接递送至身体任何部位的肿瘤，因此，对患有播散性化疗难治性卵巢癌的女性进行临床开发很感兴趣。美国国家癌症研究所 (NCI) 利用以前在卵巢癌中的放射性药物临床应用经验来增强其对结合放射性药物的思考，这些药物未来可能会考虑用于化疗难治性卵巢癌患者的治疗。由于阿尔茨海默病和其他形式的痴呆症患病率不断上升，市场增长可能会有所贡献。其他因素包括老年人口的增长、提供先进放射性药物产品的市场领导者的存在、该地区医院和其他医疗中心数量的增加。
就 COVID-19 而言，北美地区的感染率很高。尤其是美国受到影响。 COVID-19 大流行对美国放射性药物市场产生了重大影响。根据核医学和分子成像协会 (SNMMI) 的数据，近 80% 的受访者认为非 PET 核医学手术减少了 50%-75%。此外，据报道，COVID-19 改变了核医学 (NM) 部门放射性药物制剂的政策，对放射性药剂实验室的正常运行产生了负面影响。 COVID-19 对大多数行业都具有潜在的经济影响，包括肿瘤治疗。这种流行病阻碍了癌症诊断和手术，并可能对市场产生负面影响。由于人口老龄化、不良生活方式等健康风险因素的增加以及有利的监管变化而采用新技术，预计美国放射性药物市场将出现适度增长。然而，大型成像系统安装基础的饱和和医院的整合将阻碍整体市场的扩张。此外，这一流行病极大地影响了全球放射性药剂实验室的活动。大流行影响了日程安排标准，大多数员工被鼓励呆在家里或遵守社交距离。在许多放射药学实验室中，诊断成像测试数量减少，某些成像中心将其测试程序减少到几乎一半（18.2％）。因此，预计放射性药物领域市场在一段时间内将出现负增长。
市场概况与动态
北美放射性药物市场预计将从2021年的32.9697亿美元增长到2028年的61.2836亿美元；预计2021年至2028年复合年增长率为9.3%。许多医疗市场参与者将重点放在墨西哥等新兴国家，因为这些国家各种疾病的患病率上升且人均收入较低。此外，心血管疾病的患病率正在显着上升，这主要归因于生活方式的转变以及现代化设施的采用。住宅、企业和商业设施的现代化导致身体活动减少，而与生计相关的各种因素导致的压力水平不断上升。这些情况可能会引发人们罹患心血管疾病的可能性，从而增加对各种成像仪器（包括核成像技术）的需求。研究组织致力于开发先进的诊断系统，包括经济高效的高性能 PET/SPECT 系统。这些发展主要旨在将其覆盖范围扩大到无法使用先进医疗IT设施的偏远地区。新兴国家正在投入巨资开发 PET/SPECT 机器，以降低成本并为医院和其他医疗组织提供更好的使用这些机器的机会。该地区国家是公司开展金融业务并通过并购等战略规划增加收入的重要目标。因此，一些国家正在为市场参与者提供扩大影响力和客户群的重要机会，这将在未来几年推动北美市场的发展。
关键细分市场
从类型来看，诊断核医学领域在2020年北美放射性药物市场中占据最大份额。从应用领域来看，肿瘤学领域占据了较大的市场份额。 2020 年北美放射性药物市场。此外，按 2020 年最终用户计算，医院部门在北美放射性药物市场中占有较大份额。
主要来源和公司列出
准备本北美放射性药物市场报告时提到的一些主要一手和二手来源是公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司是Advanced Accelerator Applications；拜耳公司；布拉科成像公司；康德乐健康公司；锔; ECZACIBA？I MONROL 核产品有限公司；通用电气; Lantheus 医学影像公司；诺迪恩；和 NTP 无线电同位素。
购买报告的理由
- 了解北美放射性药物市场格局，并确定最有可能保证丰厚回报的细分市场
- 了解北美放射性药物市场不断变化的竞争格局，在竞争中保持领先
- 通过识别最有可能销售的细分市场，有效规划北美放射性药物市场的并购和合作交易
- 帮助通过对市场表现的敏锐和全面分析，做出明智的业务决策北美放射性药物市场各个细分市场
- 获取北美地区 2021-2028 年各个细分市场的市场收入预测。
北美放射性药物市场细分
北美放射性药物市场 - 按类型
- 诊断核医学
- SPECT
- PET
- 治疗核医学
- α发射体
- β发射体
- 近距离放射治疗同位素
北美放射性药物市场 - 按应用
- 肿瘤学
- 心脏病学
- 神经学
- 其他
北美放射性药物市场 - 最终用户
- 医院
- 影像中心
- 学术和研究中心
- 其他
北美放射性药物市场 - 按国家/地区
- 美国
- 加拿大
- 墨西哥
北美放射性药物市场 - 公司简介
- 先进加速器应用
- 拜耳公司
- Bracco Imaging SpA
- Cardinal Health Inc
- 锔
- ECZACIBA？I MONROL NUCLEAR PRODUCTS CO.
- 通用电气
- Lantheus Medical Imaging, Inc.
- Nordion
- NTP 放射性同位素
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Radiopharmaceuticals Market – By Type
1.3.2 North America Radiopharmaceuticals Market – By Application
1.3.3 North America Radiopharmaceuticals Market – By End User
1.3.4 North America Radiopharmaceuticals Market– By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Radiopharmaceuticals Market– Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Radiopharmaceuticals Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Felicity of Alpha Radio Immunotherapy in Targeted Cancer Treatment
5.1.2 Growing Advancements in Nuclear Imaging Techniques
5.2 Market Restraints
5.2.1 Presence of Substitutes
5.3 Market Opportunities
5.3.1 Growth Potential in Several Countries
5.4 Future Trends
5.4.1 Rising Use of Nuclear Medicines for Personalized Treatment
5.5 Impact Analysis
6. Radiopharmaceuticals Market– North America Analysis
6.1 North America Radiopharmaceuticals Market Revenue Forecast and Analysis
7. North America Radiopharmaceuticals Market Analysis – By Type
7.1 Overview
7.2 North America Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)
7.3 Diagnostic Nuclear Medicine
7.3.1 Overview
7.3.2 Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 SPECT
7.3.3.1 Overview
7.3.3.2 SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 PET
7.3.4.1 Overview
7.3.4.2 PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Therapeutic Nuclear Medicine
7.4.1 Overview
7.4.2 Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Alpha Emitters
7.4.3.1 Overview
7.4.3.2 Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Beta Emitters
7.4.4.1 Overview
7.4.4.2 Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Brachytherapy Isotopes
7.4.5.1 Overview
7.4.5.2 Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Radiopharmaceuticals Market Analysis – By Application
8.1 Overview
8.2 North America Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)
8.3 Oncology
8.3.1 Overview
8.3.2 Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Cardiology
8.4.1 Overview
8.4.2 Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Neurology
8.5.1 Overview
8.5.2 Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Radiopharmaceuticals Market Analysis – By End User
9.1 Overview
9.2 North America Radiopharmaceuticals Market Share, by End User, 2021 and 2028, (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Imaging Centres
9.4.1 Overview
9.4.2 Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Centers
9.5.1 Overview
9.5.2 Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Radiopharmaceuticals Market – Country Analysis
10.1 North America: Radiopharmaceuticals Market
10.1.1 Overview
10.1.2 North America: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 US: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 US: Radiopharmaceuticals Market, by Type, 2019–2028 (USD Million)
10.1.2.1.2.1 US: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
10.1.2.1.2.2 US: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
10.1.2.1.3 US: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)
10.1.2.1.4 US: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)
10.1.2.2 Canada: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Canada: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Canada: Radiopharmaceuticals Market, by Type, 2019–2028 (USD Million)
10.1.2.2.2.1 North America: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
10.1.2.2.2.2 North America: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
10.1.2.2.3 Canada: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)
10.1.2.2.4 Canada: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)
10.1.2.3 Mexico: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Mexico: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 Mexico: Radiopharmaceuticals Market, by Type – 2019–2028 (USD Million)
10.1.2.3.2.1 Mexico: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
10.1.2.3.2.2 Mexico: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
10.1.2.3.3 Mexico: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)
10.1.2.3.4 Mexico: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)
11. Impact Of COVID-19 Pandemic on North America Radiopharmaceuticals Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Inorganic Growth Strategies
12.2.1 Overview
12.3 Organic Growth Strategies
12.3.1 Overview
13. Company Profiles
13.1 Cardinal Health Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Curium
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GENERAL ELECTRIC
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Lantheus Medical Imaging, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bayer AG
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Bracco Imaging S.p.A
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 ECZACIBA?I MONROL NUCLEAR PRODUCTS CO.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Nordion
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 NTP RADIOISOTOPES
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Advanced Accelerator Applications
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Table 2. US Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 3. US Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 4. US Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 5. US Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 6. US Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. North America Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 9. North America Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Recent Inorganic Growth Strategies
Table 18. Recent Organic Growth Strategies
Table 19. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Radiopharmaceuticals Market Segmentation
Figure 2. North America Radiopharmaceuticals Market Segmentation, By Country
Figure 3. North America Radiopharmaceuticals Market Overview
Figure 4. Diagnostic Nuclear Medicine Segment Held the Largest Share of the Market in 2021
Figure 5. The US to Show Significant Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. North America Radiopharmaceuticals Market Impact Analysis of Drivers and Restraints
Figure 8. North America Radiopharmaceuticals Market– Revenue Forecast and Analysis
Figure 9. North America Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)
Figure 10. North America Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. North America SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. North America PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. North America Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. North America Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. North America Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. North America Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)
Figure 18. North America Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. North America Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. North America Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America Radiopharmaceuticals Market Share, by End User, 2021 and 2028 (%)
Figure 23. North America Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. North America Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. North America Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. North America Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. North America: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)
Figure 28. North America: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
Figure 29. US: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. Canada: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. Mexico: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Impact of COVID-19 Pandemic in North American Country Markets
- Advanced Accelerator Applications
- Bayer AG
- Bracco Imaging S.p.A
- Cardinal Health Inc
- Curium
- ECZACIBA?I MONROL NUCLEAR PRODUCTS CO.
- GENERAL ELECTRIC
- Lantheus Medical Imaging, Inc.
- Nordion
- NTP RADIOISOTOPES
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America radiopharmaceuticals market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America radiopharmaceuticals market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the radiopharmaceuticals market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution